Cramer makes the call on viewers' favorite stocks.   Read More

Following are the day’s biggest winners and losers. Find out why shares of Sprint and Data Domain popped while U.S. Steel and Mosaic dropped.   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Whenever a politician, government agency or company puts out news late on a Friday chances are it probably isn't good or it's stuff they'd like to just slip under the door.    Read More

have two reasons to exhale on this TGIF. My month-long stint on the graveyard shift anchoring "Worldwide Exchange" is over and Dendreon is done...for now. After all, Dendreon and its prostate cancer treatment Provenge is the story that just keeps on giving.    Read More

Shares of San Diego-based Sequenom are sinking on huge trading volume. The company shocked investors after the closing bell yesterday when it issued this press release announcing that its data couldn't be trusted.    Read More

Cramer makes the call on viewers' favorite stocks.   Read More

In this Web Extra, find out why shares of Dendreon and Barclays popped while Amazon and Massey Energy dropped.   Read More

The herky-jerky, stop-and-go cab ride I'm taking right now to O'Hare ain't nuthin' compared to yesterday's roller coaster ride at Chicago's McCormick Place. And can I just say? Is Dendreon  a giant magnet for high drama and intrigue or what?    Read More

A biotech presented a major breakthrough in cancer therapy on Tuesday, yet its stock plunged. What's going on?   Read More